Skip to main content

Table 4 Occurrence of PDR Pathogens and Clinical Outcomes and in Each Severity Class Assessed by the Pneumonia Severity Index in Patients

From: Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital

Pneumonia Severity Index Classes

HCAP

(n= 231)

CAP

(n= 296)

P-value

PDR pathogensa

   

   Low (I-III)

7/17 (41.2)

5/36 (13.9)

0.027

   Intermediate (IV)

14/40 (35.0)

5/29 (17.2)

0.103

   High (V)

8/22 (36.4)

4/18 (22.2)

0.332

Early treatment failure b

   

   Low (I-III)

9/55 (16.4)

10/159 (6.3)

0.024

   Intermediate (IV)

21/115 (18.3)

18/99 (18.2)

0.988

   High (V)

26/61 (42.6)

9/38 (23.7)

0.055

In-hospital mortality b

   

   Low (I-III)

9/55 (16.4)

5/159 (3.1)

0.001

   Intermediate (IV)

29/115 (25.2)

14/99 (14.1)

0.044

   High (V)

27/61 (44.3)

13/38 (34.2)

0.322

  1. a Number of patients/total number of patients whose causative pathogens were identified in each pneumonia severity index class (percentages).
  2. b Data are presented as number of patients/total number of patients in each pneumonia severity index class (percentages).
  3. HCAP healthcare-associated pneumonia
  4. CAP community-acquired pneumonia
  5. PDR potentially drug-resistant